Search

Date 2022 Author/Creator Coudert, Mathieu

1. Continuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial. Issue 2 (14th November 2022)

Authors:
Battelino, Tadej; Danne, Thomas; Edelman, Steve V.; Choudhary, Pratik; Renard, Eric; Westerbacka, Jukka; Mukherjee, Bhaswati; Pilorget, Valerie; Coudert, Mathieu; Bergenstal, Richard M.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 25:Issue 2(2023)
Page Start:
545
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. IGlarLixi versus basal plus Rapid‐Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real‐World study. Issue 1 (19th September 2022)

Authors:
McCrimmon, Rory J.; Cheng, Alice Y.Y.; Galstyan, Gagik; Djaballah, Khier; Li, Xuan; Coudert, Mathieu; Frias, Juan P.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 25:Issue 1(2023)
Page Start:
68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial. Issue 12 (23rd August 2022)

Authors:
Polonsky, William H.; Giorgino, Francesco; Rosenstock, Julio; Whitmire, Katherine; Lew, Elisheva; Coudert, Mathieu; Alvarez, Agustina; Nicholls, Charlie; McCrimmon, Rory J.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 24:Issue 12(2022)
Page Start:
2364
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search